Spinal Muscular Atrophy Type 3
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Spinal Muscular Atrophy Type 3

What is the definition of Spinal Muscular Atrophy Type 3?
Spinal muscular atrophy type 3 (SMA3) is a mild form of an inherited (genetic) neuromuscular disease characterized by decreased muscle tone and weakness (atrophy). Spinal muscular atrophy type 3 is caused by a degeneration of the lower motor neurons in the brain stem and spinal cord that control muscle movement. Spinal muscular atrophy type 3 mainly affects infants and children.
What are the symptoms of Spinal Muscular Atrophy Type 3?
Symptoms of spinal muscular atrophy type 3 usually appear after the first 18 months of life but can also have a later onset in early adulthood. Symptoms of spinal muscular atrophy include mild muscle weakness, difficulty walking, running, and climbing up and down stairs, and frequent respiratory infections.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Spinal Muscular Atrophy Type 3?
There is currently no cure for spinal muscular atrophy type 3. Promising new treatments include disease-modifying therapies that stimulate the production of the spinal motor neuron protein (SMP), such as intrathecal (injected into spinal canal) Nusinersin (Spinraza) and oral risdaplam (Evrysdi). Other treatments for spinal muscular atrophy type 3 are mainly focused on alleviating symptoms and improving quality of life and may include physical therapy; occupational therapy; and the use of assistive devices, such as braces crutches, walkers and wheelchairs.
Who are the top Spinal Muscular Atrophy Type 3 Local Doctors?
Distinguished in Spinal Muscular Atrophy Type 3
Neuromusculoskeletal Medicine | Neurology
Distinguished in Spinal Muscular Atrophy Type 3
Neuromusculoskeletal Medicine | Neurology
Referral may be required

Swedish Neurology - Cherry Hill

550 17th Avenue, Suite 400, 
Seattle, WA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

"Dr. Elliott serves as Chief of Neurology for the Swedish Neuroscience Institute; Medical Director, Neuromuscular Medicine and Medical Director, ALS Clinic. He is also board-certified in Electrodiagnostic Medicine. Dr. Elliott was selected by both Seattle Magazine and Seattle Metropolitan Magazine as a Top Doctor. ""It is a privilege to practice neurology and I am honored by those who entrust their care with me. I believe that listening is the foundation upon which excellent care is built.""". Dr. Elliott is rated as a Distinguished provider by MediFind in the treatment of Spinal Muscular Atrophy Type 3. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3. Dr. Elliott is board certified in American Board Of Psychiatry And Neurology and American Board Of Electrodiagnostic Medicine. Dr. Elliott is currently accepting new patients.

Distinguished in Spinal Muscular Atrophy Type 3
Distinguished in Spinal Muscular Atrophy Type 3
Referral required

Vanderbilt Medical Group- Teleneurology

1161 21st Ave South, A-0118 Medical Center North, 
Nashville, TN 
Languages Spoken:
English
Offers Telehealth

Christopher Lee is a Neurologist practicing medicine in Nashville, Tennessee. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Spinal Muscular Atrophy Type 3. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Guillain-Barre Syndrome, and Gamma Knife Radiosurgery. Dr. Lee is board certified in American Board Of Psychiatry & Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Spinal Muscular Atrophy Type 3
Neurology
Elite in Spinal Muscular Atrophy Type 3
Neurology
Referral may be required

Office

300 Medical Plz Ste B-200, 
Los Angeles, CA 
Languages Spoken:
English
Offers Telehealth

Perry Shieh is a Neurologist practicing medicine in Los Angeles, California. Dr. Shieh is rated as an Elite provider by MediFind in the treatment of Spinal Muscular Atrophy Type 3. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Duchenne Muscular Dystrophy, Spinal Muscular Atrophy (SMA), Becker Muscular Dystrophy, and Tubular Aggregate Myopathy.

What are the latest Spinal Muscular Atrophy Type 3 Clinical Trials?
Foundation Fighting Blindness My Retina Tracker Registry

Summary: The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative diseases studied by the Foundation. It is a patient-initiated registry accessible via a secure on-line portal at www.MyRetinaTracker.org. Affected individuals who register are guided to create a profile that captures their perspective on the...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy

Summary: Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease caused by the degeneration of motor neurons in the anterior horn of the spinal cord, due to the absence of the SMN1 gene and the resulting lack of SMN protein. Some patients with particularly severe forms (types 0 or 1) die before the age of 2 in the absence of treatment, while others retain autonomous walking throughout...